Research Article

Cortical AAV-CNTF Gene Therapy Combined with Intraspinal Mesenchymal Precursor Cell Transplantation Promotes Functional and Morphological Outcomes after Spinal Cord Injury in Adult Rats

Figure 4

Functional hindlimb recovery promoted after AAV-CNTF gene therapy and cellular transplantation as assessed by open-field locomotion (BBB). Significant functional improvements were observed following AAV-CNTFmCherry (red), AAV-CNTFmCherry + nonviable rMPC (black), and AAV-CNTFmCherry + viable rMPC (blue) treatment compared to AAV-GFP-treated control animals (green) generally from day 21 after SCI onwards, although statistically significant differences were not maintained at all time points ( and ). Standard deviation is shown.